Gene symbol and protein | Gene Location | All allelic disease phenotypes - locus/disease symbols |
ECEL1Endothelin-converting enzyme like 1 | 2q37.1 | * Arthrogryposis, distal, type 5D - DA5D (16.18)
|
EEF2Eukaryotic translation elongation factor 2 | 19p13.3 | * Spinocerebellar ataxia 26 - SCA26 (13.23)
|
EGR2Early growth response 2 protein | 10q21.1 | * Charcot-Marie-Tooth disease, type 1D - CMT1D (14.4, 14.34, 14.52) * Charcot-Marie-Tooth neuropathy Type 4E - CMT4E (14.4, 14.34, 14.52) * Dejerine-Sottas syndrome - DSS (14.4, 14.34, 14.52) * Neuropathy, congenital hypomyelinating, 1 - CHN1 (14.4, 14.34, 14.52)
|
ELOVL4ELOVL fatty acid elongase 4 | 6q14.1 | * Spinocerebellar ataxia 34 - SCA34 (13.31)
|
ELOVL5ELOVL fatty acid elongase 5 | 6p12.1 | * Spinocerebellar ataxia 38 - SCA38 (13.35)
|
ELP1Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein | 9q31.3 | * Neuropathy, hereditary sensory and autonomic, type III - HSAN3 (14.112, 16.3) * Familial dysautonomia (Riley-Day syndrome) - (14.112, 16.3)
|
| Xq28 | * Emery-dreifuss muscular dystrophy 1 - EDMD1 (1.2)
|
EMILIN1Elastin microfibril interfacer 1 | 2p23.3 | * Neuronopathy, distal hereditary motor, autosomal dominant 10 - HMND10 (12.33)
|
ENDOGEndonuclease G, mitochondrial | 9q34.11 | * Mitochondrial myopathy and multiple mtDNA deletions - (16.89)
|
ENO3Enolase 3, beta muscle specific | 17pter-p11 | * Glycogen storage disease XIII - GSD13 (9.16) * Enolase deficiency - ENO3 (9.16)
|
ENTPD1Ectonucleoside triphosphate diphosphohydrolase 1 | 10q24.1 | * Spastic paraplegia 64, autosomal recessive - SPG64 (15.64)
|
ERBB3V-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 12q13 | * Lethal congenital contracture syndrome 2 - LCCS2 (12.88)
|
ERBB4V-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 4 | 2q34 | * Amyotrophic lateral sclerosis 19 - ALS19 (12.70)
|
ERLIN1Endoplasmic reticulum lipid raft-associated protein 1 (Erlin-1) | 10q24.31 | * Spastic paraplegia 62 autosomal recessive - SPG62 (15.62)
|
ERLIN2ER lipid raft associated 2 | 8p12-p11.21 | * Spastic paraplegia 18 - SPG18 (15.10, 15.33) * Spastic paraplegia 18A7, autosomal dominant - SPG18A (15.10, 15.33)
|
ETFAElectron-transfer-flavoprotein, alpha polypeptide(M) | 15q23-q25 | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIA) - GAIIA (9.21)
|
ETFBElectron-transfer-flavoprotein, beta polypeptide(M) | 19q13.3-q13.4 | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIB) - GAIIB (9.22)
|
ETFDHElectron-transferring-flavoprotein dehydrogenase(M) | 4q32-q35 | * Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIC) - GAIIC (9.23) * Multiple acyl-coa dehydrogenase deficiency - MADD (9.23)
|
EXOSC3Exosome component 3 | 9p13.2 | * Spinal muscular atrophy with pontocerebellar hypoplasia, type 1b - PCH1B (12.99)
|
EXOSC8Exosome component 8 | 13q13.1 | * Spinal muscular atrophy and cerebellar hypoplasia - (12.8)
|
EXOSC9Exosome component 9 | 4q27 | * Pontocerebellar hypoplasia, type 1D - PCH1D (12.9)
|
| 6q23-24 | * Deafness, autosomal dominant nonsyndromic sensorineural 10 - DFNA10 (10.48) * Cardiomyopathy, dilated, 1J - CMD1J (10.48)
|